This page is available in multiple languages
Select Language

Initial public offering of Genticel on Euronext Paris


Benedikt Timmerman, CEO & Founder of Genticel, opens the trading day in Paris.

Genticel is a French pharmaceutical company, specialising in the development of therapeutic vaccines aimed at eliminating, at an early stage, the Human Papilloma Virus (HPV) responsible for cervical cancer.